Beam Therapeutics - Stock Price History | BEAM

Historical daily share price chart and data for Beam Therapeutics since 2021 adjusted for splits. The latest closing stock price for Beam Therapeutics as of September 23, 2021 is 98.13.
  • The all-time high Beam Therapeutics stock closing price was 133.60 on July 01, 2021.
  • The Beam Therapeutics 52-week high stock price is 138.52, which is 41.2% above the current share price.
  • The Beam Therapeutics 52-week low stock price is 22.13, which is 77.4% below the current share price.
  • The average Beam Therapeutics stock price for the last 52 weeks is 80.08.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Beam Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 30.2120 18.7500 95.6300 13.3100 81.6400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.335B $0.000B
Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71